An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder

Biological Psychiatry

Volumn 54, Issue 1, 2003, Pages 9-16

  Wilens, Timothy E ^a   Prince, Jefferson B ^a   Spencer, Thomas ^a   Van Patten, Stephanie L ^a   Doyle, Robert ^a   Girard, Kristine ^a   Hammerness, Paul ^a   Goldman, Sarah ^a   Brown, Sarah ^a   Biederman, Joseph ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

ADHD; Adults; Bipolar disorder; Pharmacotherapy

Indexed keywords

AMFEBUTAMONE; NEUROLEPTIC AGENT; TRANQUILIZER;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CLINICAL ARTICLE; CLINICAL FEATURE; CONSTIPATION; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEADACHE; HUMAN; INSOMNIA; MALE; MANIA; NAUSEA; OPEN STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOPHARMACOLOGY; RATING SCALE; SCORING SYSTEM; STOMACH PAIN; SUSTAINED RELEASE PREPARATION; TREATMENT OUTCOME; XEROSTOMIA;

ADULT; AFFECT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIPOLAR DISORDER; BUPROPION; DELAYED-ACTION PREPARATIONS; DOPAMINE UPTAKE INHIBITORS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME;

EID: 0038771154     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(02)01664-5     Document Type: Article

References (65)

1. Ambrosini P.J. Historical development and present status of the schedule for affective disorders and schizophrenia for school-age children (K-SADS). J Am Acad Child Adolesc Psychiatry. 39:2000;49-58.
2. Diagnostic and Statistical Manual of Mental Disorders. 4th ed:1994;American Psychiatric Association Press, Washington, DC.
3. Ascher J.A., Cole J.O., Colin J., Feighner J.P., Ferris R.M., Fibiger H.C., et al. Bupropion A review of its mechanism of antidepressant activity . J Clin Psychiatry. 56:1995;395-401.
4. Ashgari V., Sanyal S., Buchwaldt S., Paterson A., Jovanovic V., VanTol H. Modulation of intracellular cyclic AMP levels by different human dopamine d4 receptor variants. J Neurochem. 65:1995;1157-1165.
5. Barkley R.A. Attention Deficit Hyperactivity Disorder A Handbook for Diagnosis and Treatment . 1990;Guilford Press, New York.
6. Barkley R.A., Biederman J. Toward a broader definition of the age-of-onset criterion for attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 36:1997;1204-1210.
7. Barrickman L., Perry P., Allen A., Kuperman S., Arndt S.V., Herrmann K.J., et al. Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 34:1995;649-657.
8. Beck A.T., Ward C.E., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 4:1961;561-571.
9. Benazzi F. Sensitivity and specificity of clinical markers for the diagnosis of bipolar II disorder. Compr Psychiatry. 42:2001;461-465.
10. Biederman J. Resolved Mania is mistaken for ADHD in prepubertal children . J Am Acad Child Adolesc Psychiatry. 37:1998;1091-1099.
11. Biederman J., Faraone S., Milberger S., Guite J., Mick E., Chen L., et al. A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders. Arch Gen Psychiatry. 53:1996;437-446.
12. Biederman J., Mick E., Prince J., Bostic I.Q., Wilens T.E., Spencer T., et al. Systematic chart review of the pharmacologic treatment of comorbid attention deficit hyperactivity disorder in youth with bipolar disorder. J Child Adolesc Psychopharmacol. 9:1999;247-256.
13. Biederman J., Spencer T. Attention deficit hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol Psychiatry. 46:1999;1234-1242.
14. Casat C.D., Pleasants D.Z., Fleet J.V.W. A double blind trial of bupropion in children with attention deficit disorder. Psychopharmacol Bull. 23:1987;120-122.
15. Compton M.T., Nemeroff C.B. The treatment of bipolar depression. J Clin Psychiatry. 61(Suppl):2000;57-67.
16. Conners C.K., Casat C.D., Gualtieri C.T., Weller E., Reader M., Reiss A., et al. Bupropion hydrochloride in attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry. 35:1996;1314-1321.
17. Daviss W.B., Bentivoglio P., Racusin R., Brown K.M., Bostic J.Q., Wiley L. Bupropion SR in adolescents with combined attention-deficit/hyperactivity disorder and depression. J Am Acad Child Adolesc Psychiatry. 40:2001;307-314.
18. DelBello M.P., Soutullo C.A., Hendricks W., Niemeier R.T., McElroy S.L., Strakowski S.M. Prior stimulant treatment in adolescents with bipolar disorder Association with age at onset . Bipolar Disord. 3:2001;53-57.
19. Dunner D.L., Tay L.K. Diagnostic reliability of the history of hypomania in bipolar II patients and patients with major depression. Compr Psychiatry. 34:1993;303-307.
20. DuPaul G., Power T., Anastopoulos A., Reid R. ADHD Rating Scale IV Checklists, Norms, and Clinical Interpretation . 1998;Guilford Press, New York.
21. Faraone S., Biederman J., Milberger S. How reliable are maternal reports of their children's psychopathology? One year recall of psychiatric diagnoses of ADHD children . J Am Acad Child Adolesc Psychiatry. 34:1995;1001-1008.
22. Faraone S.V., Biederman J., Mennin D., Russell R.L. Bipolar and antisocial disorders among relatives of ADHD children Parsing familial subtypes of illness . Am J Med Genet. 81:1998;108-116.
23. Faraone S.V., Biederman J., Weiffenbach B., Keith T., Chu M.P., Weaver A., et al. Dopamine D4 gene 7-repeat allele and attention deficit hyperactivity disorder. Am J Psychiatry. 156:1999;768-770.
24. Faries D., Yalcin I., Harder D., Heiligenstein J. Validation of the ADHD rating scale as a clinician administered and scored instrument. J Atten Disord. 5:2001;107-115.
25. Ferris R.M., Cooper B.R., Maxwell R.A. Studies of bupropion's mechanism of antidepressant activity. J Clin Psychiatry. 44:1983;74-78.
26. Findling R.L., Schwartz M.A., Flannery D.J., Manos M.J. Venlafaxine in adults with attention-deficit/hyperactivity disorder An open clinical trial . J Clin Psychiatry. 57:1996;184-189.
27. First M., Spitzer R., Gibbon M., Williams J.B. Structured Clinical Interview for DSM-IV Axis I Disorders. 1997;American Psychiatric Press, Washington, DC.
28. Frances A.J., Kahn D.A., Carpenter D., Docherty J.P., Donovan S.L. The Expert Consensus Guidelines for treating depression in bipolar disorder. J Clin Psychiatry. 59:(Suppl):1998;73-79.
29. Grossman F., Potter W.Z., Brown E.A., Maislin G. A double-blind study comparing idazoxan and bupropion in bipolar depressed patients. J Affect Disord. 56:1999;237-243.
30. Hamilton M. The measurement of anxiety states by rating. Br J Med Psychol. 32:1959;50-55.
31. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:1960;56-62.
32. Hartmann P.M. Strategies for managing depression complicated by bipolar disorder, suicidal ideation, or psychotic features. J Am Board Fam Pract. 9:1996;261-269.
33. Haykal R.F., Akiskal H.S. Bupropion as a promising approach to rapid cycling bipolar II patients. J Clin Psychiatry. 51:1990;450-455.
34. Hollingshead A.B. Four Factor Index of Social Status. 1975;Yale University Press, New Haven, CT.
35. Klein R.G., Pine D.S., Klein D.F. Resolved Mania is mistaken for ADHD in prepubertal childrenNegative . J Am Acad Child Adolesc Psychiatry. 37:1998;1093-1095.
36. LaHoste G.J., Swanson J.M., Wigal S.B., Glabe C., Wigal T., King N., et al. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry. 1:1996;121-124.
37. Landis J.R., Koch G.G. The measurement of observer agreement for categorical data. Biometrics. 33:1977;159-174.
38. Leon S., Riggs P., Coffman L., Mikulich S. An open trial of bupropion for ADHD in adolescents with conduct disorder and substance use disorder. NIDA Res Monogr. 178:1998;252.
39. Levin E. Nicotinic systems and cognitive function. Psychopharmaology. 108:1992;417-431. (Berl).
40. Murphy K., Barkley R.A. Preliminary normative data on DSM IV criteria for adults. The ADHD Report. 3:1995;6-7.
41. Murphy P., Schachar R. Use of self-ratings in the assessment of symptoms of attention deficit hyperactivity disorder in adults. Am J Psychiatry. 157:2000;1156-1159.
42. CGI (Clinical Global Impression Scale) - NIMH. Psychopharmacol Bull. 21:1985;839-844.
43. Sachs G.S., Baldassano C.F., Truman C.J., Guille C. Comorbidity of attention deficit hyperactivity disorder with early- and late-onset bipolar disorder. Am J Psychiatry. 157:2000;466-468.
44. Sachs G.S., Lafer B., Stoll A.L., Banov M., Thibault A.B., Tohen M., et al. A double-blind trial of bupropion versus desipramine for bipolar depression. J Clin Psychiatry. 55:1994;391-393.
45. Shih T., Khachaturian Z., Barry H. III, Hanin I. Cholinergic mediation of the inhibitory effect of methylpheniate on neuronal activity in the recticular formation. Neuropharmacology. 15:1976;55-60.
46. Spencer T., Biederman J., Wilens T. Attention-deficit/hyperactivity disorder and comorbidity. Pediatr Clin North Am. 46:1999;915-927.
47. Spencer T., Biederman J., Wilens T., Faraone S., Prince J., Girard K., et al. Efficacy of a mixed amphetamine salts compound in adults with attention- deficit/hyperactivity disorder. Arch Gen Psychiatry. 58:2001;775-782.
48. Spencer T., Biederman J., Wilens T., Harding M., O'Donnell D., Griffin S. Pharmacotherapy of attention deficit disorder across the life cycle. J Am Acad Child Adolesc Psychiatry. 35:1996;409-432.
49. Spencer T., Biederman J., Wilens T., Prince J., Hatch M., Jones J., et al. Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. Am J Psychiatry. 155:1998;693-695.
50. Spencer T., Wilens T.E., Biederman J., Faraone S.V., Ablon S., Lapey K. A double blind, crossover comparison of methylphenidate and placebo in adults with childhood onset attention deficit hyperactivity disorder. Arch Gen Psychiatry. 52:1995;434-443.
51. Stein M.A., Sandoval R., Szumowski E., Roizen N., Reinecke M.A., Blondin T.A., et al. Psychometric characteristics of the Wender Utah rating scale Reliability and factor structure for men and women . Psychopharmacol Bull. 31:1995;425-433.
52. Thase M.E., Sachs G.S. Bipolar depression Pharmacotherapy and related therapeutic strategies . Biol Psychiatry. 48:2000;558-572.
53. Ward M.F., Wender P.H., Reimherr F.W. The Wender Utah rating scale An aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder . Am J Psychiatry. 150:1993;885-890.
54. Wender P.H., Reimherr F.W. Bupropion treatment of attention deficit hyperactivity disorder in adults. Am J Psychiatry. 147:1990;1018-1020.
55. Wilens T., Biederman J., Monuteaux M., Gunawardene S., Wong J., Brown S., et al. Clinical characteristics of adults with attention deficit hyperactivity disorder and bipolar disorder. 2001;AACAP, Honolulu, HI.
56. Wilens T., Biederman J., Prince J., Spencer T.J., Faraone S.V., Warburton R., et al. Six-week, double blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry. 153:1996;1147-1153.
57. Wilens T., Biederman J., Spencer T. Pharmacotherapy of ADHD in adults A review of the literature . J Atten Disord. 4:2002;189-202.
58. Wilens T., Biederman J., Spencer T., Bostic J., Prince J., Monuteaux M.C., et al. A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder. Am J Psychiatry. 156:1999;1931-1937.
59. Wilens T., Prince J., Biederman J., Spencer T., Doyle R., Gonzalez-Heydrich J., et al. An open study of sustained-release bupropion in adults with ADHD and substance use disorders. 2001;AACAP, Honolulu, HI.
60. Wilens T., Prince J., Spencer T., Geller D., Warburton R., Moore P., et al. Double-blind comparison of desipramine and placebo in adults with attention deficit hyperactivity disorder: Preliminary results. Scientific Proceedings of the 41st Meeting of the American Academy of Child and Adolescent Psychiatry, vol 10. 1994;American Academy of Child & Adolescent Psychiatry, New York.
61. Wilens T.E., Biederman J. The stimulants. Shafer D. The Psychiatric Clinics of North America. vol 15:1992;191-222 W.B. Saunders, Philadelphia.
62. Wilens T.E., Spencer T.J., Biederman J., Girard K., Doyle R., Prince J., et al. A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. Am J Psychiatry. 158:2001;282-288.
63. Winokur G., Coryell W., Keller M., Endicott J., Leon A. A family study of manic-depressive (bipolar I) disease. Arch Gen Psychiatry. 52:1995;367-373.
64. Young R., Biggs J., Ziegler V., Meyer D. A rating scale for mania Reliability, validity and sensitvity . Br J Psychiatry. 133:1978;429-435.
65. Zametkin A., Liotta W. The neurobiology of attention-deficit/hyperactivity disorder. J Clin Psychiatry. 59(Suppl):(Suppl):1998;17-23.